Article
Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation.
Microvascular research - 1 Mar 2022
Jiang Bo, Wang Mo, Li Xue, Ren Pengwei, Li Guangxin, Wang Yuqi, Wang Lei, Li Xuan, Yang Dong, Qin Lingfeng, Xin Shijie
Abstract excerpt
Hexarelin, a synthetic growth hormone-releasing peptide, is shown to be protective in cardiovascular diseases such as myocardial infraction and atherosclerosis. However, the functional role of hexarelin in abdominal aortic aneurysm (AAA) remains undefined. The present study determined the effect of hexarelin administration (200 μg/kg twice per day) in a mouse model of elastase-induced abdominal aortic aneurysm....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
